Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: BJU Int. 2013 Dec 2;113(3):376–382. doi: 10.1111/bju.12420

Table 2.

Noninfectious pneumonitis severity by NCI Common Toxicity Criteria grade and management, (n=36).

n = Grade 1 Grade 2 Grade 3 All grades
Clinical suspicion of NIP 5 28 3 36
mTOR inhibitor therapy
   Discontinued* 0 7 2 9
   Continued 3 4 0 7
   Continued, dose reduced 0 2 0 2
   Delayed, dose reduced 0 2 0 2
   Delayed, dose maintained 0 1 0 1
NIP intervention
   Steroid initiated 2 13 3 18
   Antibiotic initiated 1 8 2 11
   Bronchodilator initiated 0 3 2 5
   Oxygen supplementation 0 0 3 3

No patients with grade 4 pneumonitis were identified.

*

Fifteen patients discontinued mTOR inhibitor therapy at time of NIP onset due to progressive disease.